AU2003204625B2 - Improved production of reticuline - Google Patents

Description

-1-

AUSTRALIA

PATENTS ACT 1990 COMPLETE SPECIFICATION FOR A STANDARD PATENT

ORIGINAL

Name of Applicant/s: Actual Inventor/s: Address for Service:

CCN:

Tasmanian Alkaloids Pty Ltd Anthony John Fist and Christopher James Byrne and Wayne Lyle Gerlach and Christopher Charles Sayer and Timothy Samuel Bailey Baldwin Shelston Waters MARGARET STREET SYDNEY NSW 2000 3710000352 Invention Title: IMPROVED PRODUCTION OF RETICULINE Details of Original Application No. 20414/99 dated 14 Jan 1999 The following statement is a full description of this invention, including the best method of performing it known to me/us:- File: 28495AUP01 500175241_1.DOC/5844

-IA-

"IMPROVED PRODUCTION OF RETICUUINE" The present application is a divisional application of Australian Application.

No.. 20414/99, which is incorporated in its. entirety herein by reference.

TECFMNCAL

FIELD

The present invention relates to the improved production of reticuline. 'More particularly, the present invention relates to the use of a nmutageni.zed Papaver Somnferum poppy plant to produce (S)-reticuline in higher yield. The Invention also relates to methods of extracting and purifying reticuline.

BACKGROUND OF THE INYENTION (S)-Reticuljne is an intermediate in the biosynthetic pathway leading to phenanthrene alkaloids. such as codeine and morphine, phthalidisoquinoline alkaloids Such as noscapine and benzylisoquinoline allkaloids such as papaverine in the Papaver .somniferum poppy (Scheme (S)-.Reticuline is present in other plants, such as Esciischolzia callfornica, Cor'ydalis cava, Fumczria officinal is, Bez-beris irulgars~ and San guinaria canadensis, and has been identified as a precursor .of protopine, benzo[clphenauthridine alkaloids such as sanguinarine, protoberberine alkaloids such as corydaline and berberine itself.

These compounds are pharmaceutically useful, for example, the analgesic properties and comamercial value of codeine and morphine require little introduction.

Noscapine is a useful antitussive compound. Papaverine is a smooth muscle relaant and a cerebral vasodilator. Berberine has been used as an antibacterial, antimalarial and antipyretic compound.

As well as being an important precursor for numerous pharmaceutical products, (S)-reticuline has recently been shown to accelerate hair growth in cultured hair cells (Biol. Pharm. Bull., 20(5) 586-588 (1997)).

12 SCHEME 1 Morphin Ucrk (Merck) Papar -er sommifcruin *Codeine.

DOi'tiraai N (sayer) 'Pizpaver sainnife-ian ,11 Protopine Oddibir (H attermann) Fuznrin officinalj 2 o NCH, O C Noseapins Capvaj (Ereluso) P Pap, amn iem SP .Papa'verfne (Bur lngton) 0 0 Sanguinanne Viadent (Horner) Satooxn N iniarad)ai Carydas car 0 0042 Batberil (Mann) (±)-Reticuline has been synthesised, by a lengthy and difficult synthesis (Tomita, M. and Kikkawa, Pharm Bull Japan, 4, 230 (1956), Chem Abs, 51, 8116 (1957) and Gopinath K Govindachari, and Viswanathan N, Ber, 92, 1657 (1959)).

The synthesis of the form has also been reported by Konda et al, Chem Pharm Bull, 23, 1063 (1975). Whilst effective, the difficulty of the totally synthetic route is that only small quantities of the compound are available after a long and costly synthesis.

Thus, total synthesis is undesirable as a means of making substantial quantities of (S)-reticuline.

A second reason for the limited availability and high cost of (S)-reticuline is that it is present in source plants at very low concentrations. For instance it is found in commercial poppy straw at 0.04%, and it is presenft in the opium of Papaver somniferum in trace amounts (Brochman-Hanssen, E. and Furaya, Planta Med. 12, 328 (1964)).

Due to the low concentrations of (S)-reticuline in the various plant sources, there is at -present no commercial source of (S)-reticuline.

(S)-Reticuline has been isolated from opium by conventional but lengthy extraction procedures. The initial step involves the mixing of powdered opium with a cationic exchange resin in hot water. The alkaloids adsorb to the ion exchange resin and the non polar fractions which are not of interest are removed by washing. The alkaloid fractions are removed by elution with methanol and can be extracted into organic solvents, such as chloroform, by using controlled acid/base extractions: for example, see the work by Brochmann-Hanssen and Furuya, 1964, Planta Med. 12, 328 and references cited therein.

Such an extraction process is expensive and involve considerable losses of opium derived material. The yield of (S)-reticuline from opium is low, Brochmann-Hanssen and Furuya reporting that it represents about 0.15% of the total opium mass. These factors all combine to render (S)-reticuline extraction from opium commercially unattractive.

Alkaloids are extracted from the poppy capsules of Papaver somniferum by two commercial methods. In one method, the immature capsule is cut and the latex collected from the wound and air dried to produce opium. In a second method, the mature poppy capsules and the poppy capsule stems are collected, and threshed to remove the seeds 4 and form a straw. When necessary, the straw is dried to a water content below 16%.

Solvent or water extraction is employed to remove the alkaloids from the straw.

Where solvent, water or super critical fluid, such as CO2, extraction is employed to remove the phenanthrene alkaloids from the straw, such method, as practiced, involves the production of "Concentrate of Poppy Straw". Concentrate of poppy straw has been defined as "The material arising when poppy straw has entered into a process for the concentration of its alkaloids, when such material is made available in trade (Multilingual Dictionary of Narcotic Drugs and Psychotropic Substances Under International Control, United Nations, New York, 1983). Concentrate of poppy straw is also defined as "the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy" 45 U.S. Federal Register 77466, November 24, 1980. For the purposes of the present specification, the term "extracted alkaloid mixture" will be used to define the crude extract extracted from poppy straw, which may contain benzylisoquinoline alkaloids, phthalidisoquinoline alkaloids and/or phenanthrene alkaloids. The "extracted alkaloid mixture" is taken to mean the crude extract of poppy straw in either liquid solid or powder form. When in liquid form, the liquid is preferably concentrated before entering commerce. The generally preferred extracted alkaloid mixture is the powder form which results form simply removing the solvent or water following extraction of the poppy straw.

As the synthesis of (S)-reticuline is economically impractical, and extraction from natural sources is low yielding and requires extensive purification, it would be desirable to increase production by increasing the amount of (S)-reticuline produced by a plant.

It is also desirable to increase the ratio of (S)-reticuline to phenanthrene-type alkaloids in the plant and the plant products. Phenanthrene alkaloids are'those incorporating the phenanthrene ring system into their structure. Morphine, codeine, thebaine and oripavine are examples of such a phenanthrene type alkaloid. Reticuline however does not include this structural element but instead is based on benzylisoquinoline as its major structural element.

Surprisingly, the present inventors have found a method of increasing (S)-reticuline production and the (S)-reticuline to phenanthrene alkaloid ratio by modifying Papaver somniferum.

It is an object of the present invention to provide a commercially viable alternative to the methods in the prior art.

It will be understood by a skilled addressee that the present invention, whilst exemplified in relation to Papaver somniferum, would be equally applicable to other plants in which (S)-reticuline is present, such as Eschscholzia californica, Corydalis cava, Fumaria officinalis, Berberis vulgaris and Sanguinaria canadensis.

In the context of the present invention, the term "opium" is taken to include material which is obtained from a modified Papaver somniferum in a similar fashion to that used to obtain opium (as conventionally defined) from a non-modified plant.

SUMMARY OF THE INVENTION In a first aspect the invention provides a stably reproducingPapaver somniferum having a higher (S)-reticuline than morphine content.

In a second aspect the invention provides a stably reproducing Papaver somniferum, which upon the harvesting of the poppy capsules will yield a poppy straw having a higher (S)-reticuline than morphine content.

In a third aspect the invention provides a stably reproducing Papaver somniferum, which upon the collection and drying of the latex from the immature poppy capsules will yield an opium having a higher (S)-reticuline than morphine content.

In a preferred embodiment the production or activity of (S)-reticuline oxidase in the stably reproducing Papaver somniferum is inhibited, with the result that upon harvesting the poppy capsules will yield a poppy straw, or upon the collection and drying of the latex from the immature-poppy capsules will yield an opium, having a higher reticuline than morphine content In another preferred embodiment the production or activity of dehydroreticuline reductase in the stably reproducing Papaver somniferum is inhibited, with the result that upon harvesting the poppy capsules will yield a poppy straw or upon the collection and drying of the latex from the immature poppy capsules will yield an opium, having a higher (S)-reticuline than morphine content.

In yet another preferred embodiment the production or activity of berberine bridge enzyme (BBE) in the stably reproducing Papaver somniferum is inhibited, with the result that upon harvesting the poppy capsules will yield a poppy straw, or upon the collection and drying of the latex from the immature poppy capsules will yield an opium, having a higher (S)-reticuline than morphine content.

In a further preferred embodiment the production or activity of two or more enzymes in a stably reproducing Papaver somniferum, selected from the group comprising: (S)-reticuline oxidase, dehydroreticuline reductase or berberine bridge enzyme (BBE), are inhibited with the result that upon harvesting the poppy capsules will yield a poppy straw, or upon the collection and drying of the latex from the immature poppy capsules will yield an opium, having a higher (S)-reticuline than morphine content Preferably, such stably reproducing Papaver somniferum yield a poppy straw having an (S)-reticuline content greater than and more preferably greater than Preferably, such stably reproducing Papaver somniferum yield opium having an (S)-reticuline content greater than 10%, and more preferably greater than Preferably, such stably reproducing Papaver somniferum yields an extracted alkaloid mixture having an (S)-reticuline content greater than 30%, and more preferably greater than Also preferred is a stably reproducing Papaver somniferum which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having an (S)-reticuline to phenanthrene alkaloid ratio of about 100% or greater. More preferred is a ratio of 200% or greater, even more preferred is a ratio of 1250% or greater and highly preferred is a ratio of about 2500%. In yet another preferred embodiment a stably reproducing Papaver somniferum, upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having substantially no phenanthrene alkaloid content.

According to a fourth aspect the invention provides a seed yielding a stably reproducing Papaver somniferum according to any one of the preceding aspects.

According to a fifth aspect the invention provides poppy straw of a stably reproducing Papaver somniferum, the threshed straw having a higher (S)-reticuline than morphine content. Preferably, the poppy straw has an (S)-reticuline content greater than more preferably greater than even more preferably the (S)-reticuline content is about 3-4% 7 Also preferred is poppy straw having (S)-reticuline to phenanthrene alkaloid ratio of 100% or greater by weight. More preferred is a ratio of 200% or greater by weight, even more preferred is a.ratio of 1250% or greater by weight and highly preferred is a ratio of about 2500%. In a further preferred embodiment the poppy straw has substantially no phenanthrene alkaloid content.

According to a sixth aspect the invention provides opium of a stably reproducing Papaver somniferum, the opium having a higher (S)-reticuline than morphine content.

Preferably, the opium has an (S)-reticuline content greater than 10% and more preferably greater than Also preferred is opium having (S)-reticuline to phenanthrene alkaloid ratio of 100% or greater by weight More preferred is a rfitio of 200% or greater by weight, even more preferred is a ratio of 1250% or greater by weight and highly preferred is a ratio of about 2500%. In a further preferred embodiment the opium has substantially no phenanthrene alkaloid content.

According to a seventh aspect the invention provides an extracted alkaloid mixture of a stably reproducing Papaver somniferum, the extracted alkaloid mixture having a higher (S)-reticuline than morphine content. Preferably, the extracted alkaloid mixture has an (S)-reticuline content greater than 30% and more preferably greater than Also preferred is an extracted alkaloid mixture having (S)-reticuline to phenanthrene alkaloid ratio of 100% or greater by weight More preferred is a ratio of 200% or greater by weight, even more preferred is a ratio of 1250% or greater by weight and highly preferred is a ratio of about 2500%. In a further preferred embodiment the extracted alkaloid mixture has substantially no phenanthrene alkaloid content.

According to an eighth aspect the invention provides a stand of a stably reproducing Papaver somniferum according to any one of the previous aspects.

According to a ninth aspect the invention provides (S)-reticuline when obtained from a stably reproducing Papaver somniferum, the poppy straw, the opium or an extracted alkaloid mixture according to any one of the previous aspects.

According to a tenth aspect the invention provides a method for the production of (S)-reticuline which comprises the steps of: a) harvesting poppy capsules of a stably reproducing Papaver somniferum to produce a straw having a higher (S)-reticuline than morphine content, and b) chemically extracting the (S)-reticuline from the straw.

According to an eleventh aspect the invention provides a method for the production of (S)-reticuline which comprises the steps of: a) collecting and drying the latex of the immature poppy capsules of a stably reproducing Papaver somniferum to produce opium having a higher (S)-reticuline than morphine content, and b) chemically extracting the (S)-reticuline from the opium.

Preferably, in such methods, stably reproducing Papaver somniferum yield a poppy straw having an (S)-reticuline content greater than more preferably greater than even more preferably the (S)-reticuline content is about 3-4%.

Preferably, in such methods stably reproducing Papaver somniferum yield an opium having an (S)-reticuline content greater than 10%, and more preferably greater than The invention also consists in (S)-reticuline when obtained by any of the forgoing processes.

According to a twelfth aspect the invention provides a method to improve the (S)-reticuline yield of a stably reproducing Papaver somniferum, the method comprising the steps of: a) exposing at least one poppy seed of Papaver somniferum to a mutagenizing agent, b) growing the at least one poppy seed to produce a plant bearing a leaf or an immature poppy capsule, optionally through multiple self fertilized generations, c) sampling the leaf or poppy capsule for the presence of (S)-reticuline, morphine and codeine, and d) repeating steps a) to c) until a poppy plant of Papaver somniferum is obtained having a higher (S)-reticuline than morphine content as an expressed, stable heritable trait.

Preferably steps a) to c) are repeated until the (S)-reticuline content shows no further increase on mutagenesis.

According to a thirteenth aspect there is provided a method for the production of (S)-reticuline which comprises the steps of: a) harvesting poppy capsules of a stably reproducing Papaver somniferum to produce a straw wherein the straw has an (S)-reticuline to phenanthrene alkaloid ratio of 100% or greater by weight, and b) chemically extracting the (S)-reticuline from the straw.

According to a fourteenth aspect there is provided a method for the production of (S)-reticuline which comprises the steps of: a) collecting and drying the latex of the immature poppy capsules of a stably reproducing Papaver somniferum to produce opium wherein the opium has an (S)-reticuline to phenanthrene alkaloid ratio of 100% or greater by weight, and b) chemically extracting the (S)-reticuline from the opium.

According to a fifteenth aspect there is provided a method to improve the (S)-reticuline yield of a stably reproducing Papaver somniferum, the method comprising the steps of: a) exposing at least one poppy seed of Papaver somniferum to a mutagenizing agent, b) growing the at least one poppy seed to produce a plant bearing a leaf or an immature poppy capsule, optionally through multiple self fertilized generations, c) sampling the leaf or poppy capsule for the presence of (S)-reticuline, morphine and codeine, and d) repeating steps a) to c) until a poppy plant of Papaver somniferum is obtained having an (S)-reticuline to phenanthrene alkaloid ratio of 100% or greater by weight.

Preferably in the aforementioned products and methods, the (S)-reticuline to phenanthrene alkaloid ratio is 200% or greater by weight, even more preferably the ratio is 1250% or greater and highly preferred is a ratio of about 2500%.

It is also highly preferred that there are substantially no phenanthrene alkaloids present.

The invention also consists in (S)-reticuline when obtained from any of the forgoing plants or plant products.

According to a sixteenth aspect there is provided a method for purifying reticuline from an aqueous extract of poppy straw comprising the following steps: mix said extract with toluene at near neutral pH and separate the aqueous and the non-aqueous phases, (ii) mix aqueous phase from step (ii) with toluene at pH of about 8.5 to about 9.5 and separate the aqueous and the non-aqueous phases, (iii) extract reticuline from the non-aqueous phase by caustic extraction.

Preferably the method further comprises the steps of (iv) mixing caustic extract of step (iii) with toluene at alkaline pH and separating the aqueous and the non-aqueous phases, mixing the non-aqueous phase from step (iv) with water at acidic pH, and.

separating the aqueous and the non-aqueous phases, (vi) adding alkali to aqueous phase at ambient temperature, ageing for a time sufficient to induce formation of a precipitate and collecting precipitate containing reticuline.

Unless the context clearly requires otherwise, throughout the description and the claims, the words 'comprise', 'comprising', and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of "including, but not limited to".

Those skilled in the art will appreciate also that there are other methods of affecting the targeted enzymes to increase the accumulation of (S)-reticuline, such as transfection and targeting of genes and/or m-RNA encoding the production of reticuline oxidase, dihydroreticuline reductase and berberine bridge enzyme (BBE).

BRIEF DESCRIPTION OF FIGURES Figure 1 shows a HPLC trace of an extract of modified Papaver somniferum (bottom line) and an extract spiked with a standard for alkaloid analysis.

DETAILED DESCRIPTION OF THE INVENTION Utilizing the mutagenized plants of Papaver somniferum as described herein, persons skilled in the art easily know how to grow and reproduce such plants, collect the i0 latex or the dried straw and purify the (S)-reticuline. As one embodiment of the present invention, seeds to the mutagenized plants of Papaver somniferum, as described herein, 11 have been deposited under the Budapest Treaty with The American Type Culture Collection, 12301 Parklawn Drive, Rockville, MD 20852, United States of America on 1 September 1998, under Accession No. PTA-206, and will be made available upon the maturation of this application into a patent. The availability of these seeds is not to be construed as a license to practice this invention in contravention of rights granted under the authority of any government in accordance with its patent or breeder's rights laws.

Methods of seed mutagenesis as well as mutagens suitable for use in these methods, such as, ethyl methanesulfonate (EMS), are described in the Manual on Mutation Breeding, 2nd ed., Vienna 1977 or in Plant Breeding, Principles and Prospects, Chapman and Hall, London 1993. For X-ray mutagenized seeds, hydrated seeds might be treated with 20,000 rads, (30cm from the source for 45 minutes using a filter). X-ray mutagenesis is described and compared to EMS mutagenesis by Filippetti, A. et al., "Improvement of Seed Yield in Vici Baba L. By Using Experimental Mutagenesis II Comparison of Gamma-Radiation and Ethyl-MethaneSulphonate

(EMS)

in Production of Morphological Mutants", Euphytica 35 (1986) 49-59. DEB, diepoxybutane, mutagenized seeds might be obtained by soaking the seeds in water overnight, then soaking in 22mM DEB for 4 hours, followed by extensive washing.

Further mutagens include ethyl-2-chloroethyl sulphide, 2 -chloroethyl-dimethylamine, ethylene oxide, ethyleneimine, dimethyl sulphonate, diethyl sulphonate, propane sulphone, beta-propiolactone, diazomethane, N-methyl-N-nitrosourethane, acridine orange and sodium azide. The preferred mutagen employed herein is EMS.

Mutagenesis utilizing EMS is well described in the literature. The Manual on Mutation Breeding, supra, reports a preferred EMS mutagenesis process for barley seeds as practiced by K. Mikaelson. In this preferred process, the seeds are prepared, presoaked, treated with the mutagen and post-washed.

In the preparation, uniform size seeds are selected and placed in mesh polyethylene bags, about 200 seeds. Subsequently, the seeds are kept in a dessicator over a 60% glycerol solution, which gives the seeds a moisture content of about 13%. In pre-soak, the seed bags are transferred to beakers with distilled or deionized water and soaked for 16 20 hours at a temperature of 20 22 0 C. The pre-soak period is important to the uptake or diffusion of mutagen. The pre-soak should be sufficient to promote diffusion of the mutagen into the seed and at the same time stimulate the embryo 12 meristem tissue to start DNA synthesis. It is at this point that high mutation frequency can be achieved with minimal chromosome damage. To treat with the mutagen, the seed bags are transferred to beakers containing a solution of EMS in distilled or deionized water. For barley and wheat, the maximal mutation frequencies are obtained under treatment conditions where the EMS concentration is 0.05 0.1 M, the bath temperature is 30 35 0 C, and the exposure time of the seeds to the bath is 0.5 2 hours. Relatively weak treatments are preferred in mass screening to achieve maximal mutation with minimal physiological damage. Such treatments give better germinability and survival, less plant growth reduction and less sterility compared with stronger treatments.

A

thorough post-wash in water after the EMS treatment is essential. This post-wash can be carried out in running tap water, preferably at not less than 15°C, for a period of not less than 4 hours. The EMS should be removed by the post-wash in order to prevent uncontrollable after-effects by the mutagen. After post-washing, the seeds should be planted as soon as possible. If the seeds cannot be planted soon after the mutagenesis process, they should be immediately dried back to a moisture content of about 13 This can be accomplished by simply air drying the seeds at room temperature and a reasonably low relative humidity.

Persons skilled in the art will recognize that this preferred mutagenesis method for barley and wheat seeds can be easily modified for poppy seeds. In the case of poppy seeds, it has been found useful and convenient by the inventors hereof to dispense with dessication, to extend the time of pre-soak to up to 48 hours and to lower the bath temperature of mutagen treatment to 20 0 C. Other modifications will be apparent to skilled practitioners.

After the seeds have been exposed to the mutagen, the seeds are grown to maturity in controlled conditions and self-pollinated. The seeds from the mature plant are taken and at least one seed is planted to grow an M2 generation. The M2 generation is screened for alkaloid production. Of course, it is possible to screen the MI generation, but there are several advantages to screening the M2 generation. Firstly, screening the M2 generation insures that the trait resulting from mutagenesis can be inherited.

Secondly, by growing the M2 generation, the basic hardiness of the plant is proven before screening. Thirdly, traits resulting from mutagenesis are generally inherited as recessive genes, and these will be homozygous in the M2 generation, i.e., 13 they will not be masked by a dominant gene. The M2 plants can be grown to produce an immature capsule, but it is possible to save time and labor if the plant is screened at an earlier stage of growth. It is recommended that the plants be screened at a point beginning at the 10 leaf stage, up to the "running-up" stage, where the plant reaches about 15 cm in height. The screening process itself is the most labor intensive. Thus, to improve return on labor, only plants that appear healthy should be screened.

In the screening process, the objective is to measure each plant for alkaloids such as morphine, codeine, oripavine, thebaine, noscapine, papaverine and any other alkaloids which might occur as a result of blockage to one or more metabolic pathways, such as (S)-reticuline. The trait of a high (S)-reticuline content relative to other alkaloids is highly desirable, and once established is highly heritable. This can be accomplished by extracting, for example, a dry leaf into a liquid buffer or by dissolving a latex sample into a buffer. The buffer solutions are placed in glass vials and loaded into 96-place carousels and fed mechanically through any of the high-throughput HPLCs available on the market.

Plants with unusual alkaloid contents are grown further and examined in more detail. According to procedure herein, a second sample is taken from about 1/20 plants to clarify the results of the initial screen.

As stated above, there is obtained by the present invention, a threshed poppy straw or opium having an (S)-reticuline content higher than -that observed in native plants. Preferably, there is substantially no codeine, morphine, thebaine or other phenanthrene alkaloid in the alkaloid combination.

The desired traits, i.e. high (S)-reticuline content versus phenanthrene alkaloid content, once established are highly heritable. To maintain the desired traits, care should be taken to prevent cross-pollination with normal plants unless such cross-pollination is part of a cbntrolled breeding program.

The theory whereby mutagenesis has been found to be capable of raising the (S)-reticuline content of Papaver somniferum relative to the phenanthrene alkaloid content is not capable of a certain or definite explanation at this time. The mutagenesis may have resulted in the modification of certain enzyme activity in a qualitative or quantitative manner. Alternatively, the mutagenesis might have modified the biosynthesis pathway in any number of ways to minimize the production of morphine 14 and codeine. Despite the fact that definite answers are not now available, there are good reasons to believe that the correct answer is known.

A postulated biosynthetic pathway in Papaver somniferum via (S)-reticuline to morphine is shown in Scheme 2 below.

SCHEME 2 CH ,0 Ho J 1

NCH'

HO

H

(S)-Reliculine (S)-Reticline c~ddase Ijil HO -AH

HO

1 .2-Oehydroreticulinfium ion reficuflnium ion NADPH

NADP-

v Ho

HOH

CH 3 0 R-Reticulmne CHO 0 cH~cH HO H Salutaridinot

ACOA

NO

HH'

SalutaidinoI7-.oadtL *Salutardine IjL reductse HO

N

NA)P' NAOPH CH 0- 0 Salutaridine CH0 Ac SalUtaridine NADPH. 0, N~o

OH

MR-Reficuline Demelivyjation Thebaine Neopinane Equifibaiun

CH

2

O

0 Demethtin codatnon NADP-

NADPH

NCH'

H

Morphine.cdieO~~nn Codeine Codeinane By the methods herein, a variety of Papaver somniferum was obtained having a high (S)-reticuline content and substantially no thebaine, codeine or morphine. Thus, it is believed, for the Papaver somniferum variety described herein, that the production or activity of (S)-reticuline oxidase has been substantially inhibited, resulting in a buildup of (S)-reticuline and less material following the biosynthetic pathway to its endpoint, i.e.

morphine. It is also possible that the production or activity of dehydroreticuline reductase has been inhibited. By feedback inhibition through 1, 2 -dehydroreticuline, this would lead to an accumulation of (S)-reticuline.

It is also possible that stably reproducing Papaver somniferum in accordance with the present invention may also be obtained by recombinant DNA techniques. In particular, after isolation and sequencing of the gene coding for (S)-reticuline oxidase, the gene or the mRNA transcript may be modified, deleted or blocked to inhibit or prevent the production of (S)-reticuline oxidase. Techniques for modifying or deleting specific regions of DNA sequences or blocking mRNA are well known to those skilled in the art.

It would also be possible to accumulate (S)-reticuline in other species by blocking particular enzymes. For example, in Berberis species, the berberine bridge enzyme could be blocked either using mutagenesis (as demonstrated here) or through recombinant DNA techniques.

Recovering (S)-reticuline from either the dried straw or from the opium of Papaver somniferum is a process well established in the art. A schematic diagram (Scheme 3) is shown outlining the process of (S)-reticuline extraction from the alkaloid containing extract of opium. This procedure was outlined by Brochmann-Hanssen and Furuya (Planta Med. 12, 328-333). Methods of obtaining of a highly acidic (pH opium extract are well known in the art. Those skilled in the art will appreciate that presently there are a number of suitable starting materials for such extractions depending on the industrial process being used, and that Scheme 3 provides one example only.

SCHEME 3 OPIUM EXTRACT pH approx. CH{C1 3 CHC1 3 ext.: Aqueous papaverine narcotine added thebaine CHC1 2

CC

laudanosine extd. witf

)OH

unknown A CHC1 3 ext.: Aqueous: narceine morphine neopine codeine, etc.

laudanine laudanidine unknowsB,C, D evapd. to dryness Residue dissolved in 0.1IN NaOH extd. with CHC1 3 CHC1 3 ext: laudanine laudanidine unknown C, D Aqueous: +NaHICO 3 extd. with ether ether phase:unknown B =Reticuline

EXAMPLES

Example 1. Mutation Seeds of Papaver somniferum were obtained of about uniform size, dried to about 8% LOD (loss on drying) and placed in a mesh polyethylene bag at a weight of about 5 grams or about 12,500 per bag. The seeds were pre-soaked in beakers of distilled water containing a phosphate buffer at room temperature for about 36 hours.

The seeds were given a further presoaking in cold 0.3% v/v (-0.028 M) ethyl methanesulphonate (EMS). Immediately after pre-soak, the seed bags were immersed in a mutagen bath containing 0.3% v/v (-0.028 M) ethyl methanesulphonate (EMS) at 20 0 C for 6 hours. Immediately following the mutagen bath, the seed bags were postwashed in running tap water. Following post-wash, the seeds were kept moist and planted within'one hour.

Example 2. Propagation The seeds were planted in outdoor plots and grown to maturity. The planting technique employed was in all respects normal for poppy trial work, and similar to commercial poppy growing. The seeds were sown using a "cone seeder" or trial plot drill. Seed depth was about 1 cm. Fertiliser containing N, P and K was used. The plots were irrigated immediately after sowing. The poppy flowers were self-pollinated and the majority of the flowers were covered with paper bags of bleached white "kraft" paper to prevent cross pollination. Seeds were harvested from those Ml generation plants which grew vigorously and appeared healthy. A second, M2, generation was grown from the harvested seeds. These seeds were planted in trays containing 200 plants. When the M2 plants were between the 10 leaf stage and the "running-up" stage, about 15 cm high, they were screened for alkaloid content using a rapid HPLC technique.

Example 3. Screening The screening process was basically a three step process. In the first step, a leaf was cut from an M2 plant and about 0.5 pL of latex was collected,at the wound. The latex was diluted in a microcentrifuge tube with 250 piL of buffer. The buffer contained 0.2 M ammonium phosphate, 20% ethanol, and had a pH of 4.5. The microcentrifuge tube was briefly held to a vortex shaker to ensure mixing. In the second step, the buffered solution was centrifuged to substantially eliminate suspended solids and about 200 uL was decanted into a 40 mm x 8 mm autoanalyser tube. Additional buffer, 250 PL, was added to each autoanalyser tube so that the sampling needle of the autoanalyser could reach the solution. In the third step, the autoanalyser tubes were loaded into a 96 place carousel inserted into the auto injector module of a Waters HPLC system. The HPLC mobile phase was aqueous methanol (approximately 30%) containing ammonium acetate buffer (0.08-0.12 pH 4-5. The flow rate of the mobile phase was 0.8-1.5 mL/minute. A Whatman Partisphere SCX column (4.6 x 125 mm) was used at a temperature of 40 0 C. A Waters 440 UV detector was used to detect the peaks at 254 nm.

The data was interpreted and collated on a Waters Millennium Data Station. The system was used to analyse for alkaloids.

Two plants E40 and E41, were screened and the latex was found to be morphine and thebaine free and contained a peak later identified as (S)-reticuline. The two plants were combined and about 0.15 g of straw was harvested and analysed. The (S)-reticuline content was with 0.007% thebaine. The reticuline was identified by circular dichroism as (S)-reticuline.

A descendant generation was grown in the field. The plants grew well, but two distinct types of plant were observed at the green capsule stage, those having white latex (E40/4 1W) and those having red latex (E40/41 From the variety with white latex was harvested 50.7 g of straw containing 3.88% (S)-reticuline and 0.78% codeine (or codeine-like alkaloids). The variety with red latex was observed to have 2.51% (S)-reticuline and zero codeine.

Example 4. Extraction An acidic extract (pH 1.5) of opium or extracted alkaloid mixture, is obtained in the usual manner. This acidic fraction is extracted with chloroform, which removes a number of alkaloids including papaverine, narcotine, thebaine and laudanosine, where present. The acidic aqueous phase is then treated with dichloroacetic acid and further extracted with chloroform. Morphine and codeine, where present, remain in the aqueous phase but a number of alkaloids, including (S)-reticuline, partition into the organic phase. The organic phase is subsequently evaporated to dryness and the residue dissolved in 0.1 M NaOH. Laudanine and laudanidine partition into the chloroform layer. The aqueous layer is treated with sodium bicarbonate and the resultant aqueous layer extracted with ether. The ether layer is found to contain (S)-reticuline.

Example 5. Analysis A HPLC trace of an E40R/41R extract is shown in Fig 1. The extract alone is the bottom trace, while the top trace is an solution containing extract and standards.

(S)-reticuline is shown as having a retention time of about 16 minutes.

Example 6. Calculation Phenanthrene alkaloids are those incorporating the phenanthrene ring system into their structure. Morphine is an example of such a phenanthrene type alkaloid.

Reticuline however does not include this in its structure but has the "benzylisoquinoline" structure as its major structural element.

In the threshed straw of commercial poppies grown in Australia, (S)-reticuline constitutes no more than 0.04%, and the sum of all the phenanthrene alkaloids (morphine, codeine, thebaine and oripavine) is of the order of depending on the variety grown and factors such as crop nutrition and rainfall received.

Thus, 0.0 4 /2.0 x 100 2% In the reticuline poppies, the concentration of (S)-reticuline in the threshed poppy straw is about whereas the concentration of the sum of the phenanthrene alkaloids is at best 0.1%.

Thus, the percentage ratio is 2.5/0.1 x 100 =2500% Example 7: Improved procedure for extraction of reticuline An improved process for the isolation of crude reticuline was developed to generate an aqueous concentrate from poppy straw. The process was then optimised to obtain a product of improved purity.

The process flowchart with mass balances is represented in Scheme 4 below.

SCEME 4 Step No.

toluene toluene 2% NaCH soin

H

3 P0 4 toulen e water

H

3 P0 4 ammonia concentrate FfiCaMi~o solid filtercake toluene wash spent aqueous spent toluene spent aqueous spent. toluene 100% (14.45 g)

T%

6% 0% 1 0% 18g) TOTAL 98% 1. Concentrate Preparation The dried ground straw was extracted with 80% ethanol at pH 4.5 (with acetic acid), and the resultant rich miscella was concentrated 8 fold under vacuum at This miscella was produced batchwise by extracting straw in 100 gram lots with 1.0 litre of solvent and 50 mLs acid for 30 minutes at 40*C. Extraction efficiency was improved by using two countercurrent extractions. The miscella was adjusted to pH 6.0 with ammonia prior to concentration by Buchi Rotavap, and the aqueous concentrate was filtered through a Celite bed.

2. Caustic Extraction of Toluene Solution A toluene wash at pH 6.8, to remove levels of impurities, was applied to the concentrate prior to toluene extraction at pH 9.2. The toluene solution at pH 9.2 contained nearly all the available (S)-reticuline, rendering the aqueous solution spent.

Oripavine can be separated and isolated from a toluene solution containing both thebaine and oripavine by caustic extractions. This procedure was applied to the reticuline process, since reticuline has phenolic properties similar to oripavine. The resultant caustic extract was rich in reticuline and coloured black, but contained significantly reduced levels of impurities.

3. Removal of Coloured Impurities.

Attempts to precipitate a solid directly from the caustic extract by adjusting to pH 9.2 with phosphoric acid did not produce a crystalline solid. The resultant precipitate was a very sticky gum which did not disperse into a slurry. The caustic solution was therefore extracted with toluene at pH 9.2. The caustic solution (now spent of alkaloid) remained black, while the toluene solution of reticuline was almost colourless. This procedure affords an excellent means for the removal of a substantial amount of colour. An acid extraction of this toluene solution gave a relatively clean aqueous concentrate from which reticuline base can be precipitated.

4. Isolation of Extracted Alkaloid mixture Dilute ammonia was slowly added to the acidic reticuline solution to adjust the pH to 9.2 while maintaining the ambient temperature at 400C. The slurry was aged for a few hours at ambient, and isolated by filtration. The cake was washed with two displacement volumes of water, and dried in vacuo at 50 0

C.

Assay Methodology The HPLC method for analyses of these experiments is shown in Table 1 below.

This isocratic method gives good separation between the main reticuline peak and the three major unknown components.

Table 1: HPLC assay method Mobile phase 27% v/v methanol, in 0.8% triethylamine, to pH 4.3 with H 3 P0 4 Flow rate 1.0 mL/min Wavelength 284 nm Column Alltech Altima C18 Retention times reticuline: 10.1 minutes Scheme 5 below details the steps of a typical process.

SCHEME Part A: Straw Extraction.

1. Take reticuline straw which is dry, free of seed and ground to a fine powder.

2. Prepare a mixture consisting of 100 grams of ground straw, 1.0 litre of solvent v/v ethanol) and 50 mLs acetic acid. Ensure the pH is in the range 4.3 4.8. Agitate at for 30 minutes.

3. Filter, and put the filtrate (rich miscella) aside.

4. Take the filtered straw and extract with 1.0 litre fresh solvent and 50 mLs acetic acid (pH 4.3 4.8) at 40 0 C for 30 minutes.

Filter, and discard the spent straw.

6. Extract a fresh lot of straw (100 g) with the filtrate from step 5, at 40°C for minutes.

7. Filter, and put the filtrate (rich miscella) aside. Extract the filtered straw with 1.0 litre fresh solvent and 50 m.Ls acetic acid at 40'C for 30 minutes (as in step 8. Repeat steps 5, 6 and 7 to process all the available straw.

9. Combine all the rich miscella and adjust the pH to 6.0-6.2 with ammonia (28% v/v).

Part B: Concentration and Purification 1. Concentrate the rich miscella under vacuum 8 to 10 fold. Do not exceed 2. Filter the resulting concentrate through a bed of Celite, and wash the bed with a cake volume of warm water; Perform steps 3 to 17 at 40 0

C.

3. Add 0.3 volumes toluene, and adjust the pH to 6.8 using 40% w/v KOH or NaOH solution. Mix for 10 minutes, settle for 15 minutes. Separate the phases.

4. Perform a second toluene wash on the aqueous phase at pH 6.8, as in step 3.

Combine the toluene washes, and treat as spent.

6. Add 0.3 volumes of toluene to the aqueous phase, and adjust the pH to 9.3 using w/v KOH solution. Mix for 10 minutes, settle for 15 minutes. Separate the phases.

7. Perform a second toluene extraction on the aqueous phase at pH 9.3, as in step 6.

8. Combine the toluene extracts, treat the aqueous phase as spent.

9. Add 0.3 volumes of a 2% w/v KOH solution to the toluene extracts. Mix for minutes, settle for 15 minutes. Separate the phases.

Perform a second caustic extraction as in step 9, and combine the caustic extracts.

Treat the toluene stream as spent solvent.

(To minimise the time that reticuline is kept in highly alkaline conditions, this caustic solution should not be stored for a long period, ie not more than 8 hours).

11. Add 0.5 volumes toluene to the caustic extracts, and adjust the pH to 9.3 using concentrated H 3

PO

4 Mix for 10 minutes, settle for 15 minutes. Separate the phases.

12. Perform a second toluene extraction at pH 9.3, as in step 11.

13. Combine the toluene extracts, treat the aqueous phase as spent.

14. Add 0.3 volumes water to the toluene extracts, and adjust the pH to 4.5 using concentrated

H

3 P0 4 Mix for 10 minutes, settle for 15 minutes. Separate the phases.

Perform a second extraction at pH 4.5, as in step 14.

16. Combine the acid extracts, treat the toluene phase as spent.

17. Slowly add 8% v/v ammonia to the acid extract to adjust the pH to 9.3. Ensure that agitation is sufficient to dissolve any localised precipitation, and adjust ammonia addition accordingly.

18. Age for 4-8 hours at ambient, filter, wash cake with two cake volumes of water, and dry the solid.

24 19. Extract the mother liquors with toluene (2 x 0.2 volumes) at pH 4.5. This toluene extract should be recycled to a later batch, or extracted into an aqueous acid solution for precipitation at pH 9.2.

The results of the process are summarised in Table 2 below.

Table 2: HPLC assay results Step Reticuline (3) aI c.dmple Colour of solution Volume (ml or g) g/L grams c c 2 1T 3 4 6-31 filtered concentrate filtercake toluene wash conc after wash spent aqueous toluene extract spent toluene caustic extract spent aqueous toluene extract spent toluene acid extract dried solid mother liquors dried 2nd crop solid (2) dark green green dark dark yellow colourless black black colourless colourless light yellow creamy yellow yellow yellow 1200 100 550 1500 1550 500 500 450 430 400 400 400 11.8 500 .2 12.04(1) 14.45 0.76 0.08 1.61 0.89 9.04 13.56 0.45 0.70 25.00 12.50 0.01 0.01 27.54 12.39 0.25 0.11 NOT ASSA 0.00 0.00 NOT ASSA 86.3% 10.18 4.25 2.13 91.0% 2.131 %age yield 100% 1% 6% 94% 87% 0% 86% 1%

YED

0%

YED

0.15 I22 Note: 1) reticuline result for filtered concentrate based on combined results for step 2.

2) 2nd crop was isolated after extraction with toluene at pH9.2, and evaporation of the extract to dryness.

Concentrations of reticuline were calculated using a laudanine standard.

Accurate quantitation of reticuline was not possible due to the lack of a reticuline standard. The results in Table 2 are relative to a laudanine standard purified locally.

Precipitation of the crystalline crude.reticuline base at pH 9.2 was very difficult due to gum formation. It was necessary to add the ammonia very slowly to allow localised precipitation to dissolve, and gum formation was minimised by adding dilute ammonia (3 fold dilution with water to 8- 10% w/w) It was observed that the relatively pure aqueous solutions of reticuline were dark yellow at pH 8, but light yellow in acidic conditions. A light-coloured acid solution of reticuline, therefore, gave rise to yellow coloured reticuline base solid.

The total quantity of crude reticuline (average assay 80%) obtained from all of the available straw was 21.5 grams as dry weight.

The process summarised in Scheme 4 (described in detail in Scheme represents a good method for the isolation of (S)-reticuline rich extracted alkaloid mixture from poppy straw. Implementation of this process on a large scale may require some minor alterations, such as the use of lime to treat the straw instead of acetic acid to reduce metal corrosion. This process could be scaled up to a factory with no specialised S apparatus being necessary for the large scale extraction of reticuline.

This process is sufficient to produce (S)-reticuline product of at least 80% purity.

Further purification may be accomplished by use a co-solvent during precipitation or isolating a salt of reticuline, such as the bitartrate or the oxalate.

The procedure described in Scheme 5 does not represent any major hazards other than those that currently exist in the morphine extraction process. No excessive temperatures or unusual solvents or reagents are required.

Although the invention has been described with reference to specific embodiments, modifications that are within the knowledge of those skilled in the art are also contemplated as being within the scope of the present invention.

0396793111 Blake Dawson Waldron 16:14:55 30-11-2006 4/24 0 0 cN 26.

0 0 Throughout this specification the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated clement, integer or step, or group of elements, integers or steps, but not to the exclusion of any other clement, integer IO or step, or group of elements, integers or steps.

0 It will be appreciated by persons skilled in the art that numerous variations and/or o modifications may be made to the invention as shown in the specific embodiments without 0 departing from the spirit or scope of the invention as broadly described. The present embodiments are, therefore, to be considered in all respects as illustrative and not restrictive.

All publications mentioned in this specification are herein incorporated by reference. Any discussion of documents, acts, materials, devices, articles or the like which has been included in the present specification is solely for the purpose of providing a context for the present invention. It is not to be taken as an admission that any or all of these matters form part of the prior art base or were common general knowledge in the field relevant to the present invention as it existed in Australia before the priority date of each claim of the application.

201O43t60o_1 COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30

Claims (34)

1. 27. 0 0 THE CLAIMS DEFINING THE INVENTION ARE AS FOLLOWS: A selected stably reproducing Papaver somnmennn having an expressed, stable heritable trait of a higher (S)-reticuline than morphine content. o2. A selected stably reproducing Papaver somniferum having an expressed, stable Cl 5 heritable trait of high (S)-reticuline content which will yield a poppy straw having an S(S)-rcticuline content greater than and more preferably greater than upon harvesting of the poppy capsules. 3. A selected stably reproducing Papaver somnif'rum having an expressed, stable heritable trait of high (S)-reticulinc content which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having an (S)-reticuline to phenanthrene alkaloid ratio of about 100% or greater by weight. 4. A stably reproducing Papaver somniferum according to any one of claims I to 3, which upon the harvesting of the poppy capsules will yield a poppy straw having a higher (S)-rcticuline than morphine content. 5. A stably reproducing Papaver somniferum according to any one of claims 1 to 3, which upon the collection and drying of the latex from immature poppy capsules will yield an opium having a higher (S)-reticuline to morphine content. 6. A stably reproducing Papwaer. somnferum according to any one of claims I to 5, in which the production or activity of (S)-reticuline oxidase is inhibited. 7. A stably reproducing Papaver somniferum according to any one of claims 1 to 5, in which the production or activity of dehydroreticuline reductase is inhibited. 8. A stably reproducing Papaversomnijrum according to any one of claims 1 to 5, in which the production or activity of berberine bridge enzyme (BBE) is inhibited. 201043696_ COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30 03 9679 3111 Blake Dawson Waldron 16:15:25 30-11-2006 6124 0 IO
2. 28. Z 9. A stably reproducing Papaver sonniferum according to any one of claims I to 5, in which the production or activity of two or more enzymes selected from the group comprising: (S)-rcticuline oxidase, dehydroreticulinc reductase or berberine bridge enzyme (BBE) are inhibited. 10. A stably reproduci ng Papaver somniferum according to any one of claims I to 9, C] which will yield an opium having an (S)-reticuline content greater than 10%, and Smore preferably greater than 20% upon collection and drying of the latex from NC immature poppy capsules. 11. A stably reproducing Pupaver somnijrunm according to any one of claims I to which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having an (S)-reticuline to phenanthrene alkaloid ratio of about 200% or greater by weight. 12. A stably reproducing Papaversomniferum according to anyone of claims I to which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having an (S)-reticuline to phenanthrene alkaloid ratio of about 1250% or greater by weight. 13. A stably reproducing Papaver somnmnfrun according to any one of claims I 10to which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having an (S)-reticuline to phenanthrcne alkaloid ratio of about 2500% by weight. 14. A stably reproducing Papaver somnfenrum according to any one of claims 1 to which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having substantially no phenanthrene alkaloid content. 15. A seed yielding a stably reproducing Papaver somnjerum according to any one of the preceding claims- 201043696_1 COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30 039679 3111 Blake Dawson Waldron 16:15:42 30-11-2006 7124 ID 0 0
3. 29. o 16. A stand of a selected stably reproducing Papaver somniferum having an expressed, stable heritable trait of high (S)-reticuline content, the stand having a higher rcticuline than morphine content. (N N 17. A stand of a selected stably reproducing Papaver somniferurn having an expressed, stable heritable trait of high (S)-reticuline content which will yield a poppy straw having an (S)-reticuline content greater than and more preferably greater than upon harvesting of the poppy capsules. 18. A stand of a selected stably reproducing Papaver somniferum having an expressed, stable heritable trait of high (S)-reticuline content which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having an (S)-reticuline to phenanthrene alkaloid ratio of about (00% or greater by weight. 19. A stand according to any one of claims 16 to 18, which upon the harvesting of the poppy capsules will yield a poppy straw having a higher (S)-rcticulinc than morphine content. A stand according to any one of claims 16 to 18, which upon the collection and drying of the latex from immature poppy capsules will yield an opium having a higher (S)-reticuline to morphine content. 21. A stand according to any one of claims 16 to 20, in which the production or activity of (S)-reticuline oxidase is inhibited. 22. A stand according to any one of claims 16 to 20, in which the production or activity of dehydroreticuline reductase is inhibited. 23. A stand according to any one of claims 16 to 20, in which the production or activity of berberine bridge enzyme (BBE) is inhibited. 24. A stand according to any one of claims 16 to 20, in which the production or activity of two or more enzymes selected from the group comprising: (S)-reticuline oxidase, dehydroreticuline reductase or bcrberine bridge enzyme (1BE) arc inhibited. 201043696_ COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30 03 9679 3111 Blake Dawson Waldron 16:15:59 30-11-2006 8124 O o 25. A stand according to any one of claims 16 to 24, which will yield an opium having an (S)-reticuline content greater than 10%, and more preferably greater than upon collection and drying of the latex from the immature poppy capsules. C<l kN 26. A stand according to any one of claims 16 to 25, which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having an (S)-reticuline to phenanthrcne alkaloid ratio of about 200% or greater by weight. 27. A stand according to any one of claims 16 to 25, which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having an (S)-reticuline to phenanthrene alkaloid ratio of about 1250% or greater by weight. 28. A stand according to any one of claims 16 to 25, which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having an (S)-reticulinc to phenanthrene alkaloid ratio of about 2500% by weight. 29. A stand according to any one of claims 16 to 25, which upon the harvesting of the poppy capsules will yield a poppy straw, an opium or an extracted alkaloid mixture having substantially no phenanthrene alkaloid content. Poppy straw of a stably reproducing Papaver somniferum according to any one of claims 1 to 14, the threshed straw having a higher (S)-reticulinc than morphine content.
4. 31. Poppy straw according to claim 30, wherein the (S)-rcticuline to phenanthrene alkaloid ratio is 100% or greater by weight.
5. 32. Poppy straw according to claim 30, wherein the (S)-reticuline to phenanthrene alkaloid ratio is 200% or greater by weight. 33, Poppy straw according to claim 30, wherein the (S)-reticuline to phenanthrene alkaloid ratio is 1250% or greater by weight. 201043696_1 COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30 039679 3111 Blake Dawson Waldron 16:16:15 30-11-2006 9124 ID 0 O 31, 0 S34. Poppy straw according to claim 30, wherein the (S)-reticuline to phenanthrene alkaloid ratio is about 2500% by weight. V)
6. 35. Poppy straw according to claim 30, having substantially no phenanthrene alkaloid N) content. C 5 36. Poppy straw according to any one of claims 30 to 35, having an (S)-reticulinc Scontent greater than and more preferably greater than 0 S37. Poppy straw according to claim 36, having an (S)-reticuline content of about 3- 4%.
7. 38. Opium of a stably reproducing P'apaver somniferum according to any one of claims I to 14, the opium having a higher (S)-reticuline than morphine content.
8. 39. Opium according to claim 38, wherein the opium has an (S)-reticuline to phenanthrene alkaloid ratio of 100% or greater by weight. Opium according to claim 38, wherein the opium has an (S)-reticuline to phenanthrene alkaloid ratio of 200% or greater by weight.
9. 41. Opium according to claim 38, wherein the opium has an (S)-reticuline to phenanthrene alkaloid ratio of 1250% or greater by weight.
10. 42. Opium according to claim 38, wherein the opium has an (S)-reticuline to phenanthrene alkaloid ratio of up to about 2500% by weight.
11. 43. Opium according to claim 38, having substantially no phenanthrene alkaloid content
12. 44. Opium according to any one of claims 38 to 43, having an (S)-reticuline content greater than 10%, and more preferably greater than Extracted alkaloid mixture of a stably reproducing Papaver somnifentn according to any one of claims .1 to 14, the extracted alkaloid mixture having a higher reticuline than morphine content.
13. 46. Extracted alkaloid mixture according to claim 45, having an (S)-reticuline to phenanthrene alkaloid ratio of 100% or greater by weight, 201041696 I COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30 03 9679 3111 Blake Dawson Waldron 16:16:32 30-11-2006 10124 VD 0 O 32.
14. 47. Extracted alkaloid mixture according to clairn 45, having an (S)-reticuline to phenanthrene alkaloid ratio of 200% or greater by weight.
15. 48. Extracted alkaloid mixture according to claim 45, having an (S)-reticuline to C] phenanthrene alkaloid ratio of 1250% or greater by weight. O 5 49. Extracted alkaloid mixture according to claim 45, having an (S)-reticuline to o phenanthrene alkaloid ratio of about 2500% or greater by weight. 0 C
16. 50. Extracted alkaloid mixture according to claim 45, having substantially no phenanthrene alkaloid content.
17. 51. Extracted alkaloid mixture according to any one of claims claim 45 to 50, having an (S)-reticuline content greater than 30%, and more preferably greater than 6 0%.
18. 52. (S)-reticul ine when obtained from a stably reproducing Papaver sommiferum according to any one of claims 1 to 14, a poppy straw according to any one of claims to 37, the opium according to any one of claims 38 to 44 or extracted alkaloid mixture according to any one of claims 45 to 51.
19. 53. A method for the production of (S)-reticuline which comprises the steps of: a) harvesting poppy capsules of a selected stably reproducing Papaver somniferum having an expressed, stable heritable trait of a higher reticuline than morphine content to produce a straw having a higher reticuline than morphine content; and b) chemically extracting the (S)-reticuline from the straw.
20. 54. A method for the production of (S)-reticuline which comprises the steps of: a) collecting and drying the latex of the immature poppy capsules of a selected stably reproducing Papaver somniferum having an expressed, stable heritable trait of a higher reticuline than morphine content, to produce 201043606_ COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30 0396793111 Blake Dawson Waldron 16:16:48 30-11-2006 11 /24 O O O33. o opium that has a higher (S)-reticuline than morphine content; and b) chemically extracting the (S)-reticuline from the opium. A method according to claim 53, wherein the stably reproducing Papaver l somnifejrum yields a poppy straw having an (S)-reticuline content greater than and more preferably greater than
21. 56. A method according to claim 54, wherein the stably reproducing Papaver somnijerum yields an opium having an reticuline content greater than 10%, and more preferably greater than
22. 57. A method according to any one of claims 53 to 56, wherein the stably reproducing Papaver sumniferum has an (S)-reticuline to phenanthrene alkaloid content of about 100% or greater by weight.
23. 58. (S)-reticuline when obtained by a method according to any one of claims 53 to 57.
24. 59. A method to improve the (S)-rcticuline yield of a stably reproducing Papaver somnifeninm, the method comprising the steps of a) exposing at least one poppy seed of Papaver somniferum to a mutagcnizing agent; b) growing the at least one poppy seed to produce a plant bearing a leaf or an immature poppy capsule, optionally through multiple self fertilized generations; c) sampling the leaf or poppy capsule for the presence of (S)-reticuline, morphine and codeine; and d) repeating steps a) to c) until a poppy plant of Papaver sommniferum is obtained having a higher (S)-reticuline than morphine content as an expressed, stable heritable trait. A method according to claim 59, wherein steps a) to c) are repeated until the reticuline content shows no further increase on mutagenesis. 20.1043606 1 COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30 039679 3111 Blake Dawson Waldron 16:17:03 30-11-2006 12/24 ID 0 O 34. o
25. 61. A method for the production of (S)-reticuline which comprises the steps of a) harvesting poppy capsules of a selected stably reproducing Papaver samtnniferum having an expressed, stable heritable trait of a higher reticuline than phenanthrene alkaloid content, to produce a straw having an (S)-reticuline to phenanthrene alkaloid ratio of 100% or greater by weight; Sand Sb) chemically extracting the (S)-reticuline from the straw.
26. 62. A method for the production of (S)-reticuline which comprises the steps of a) collecting and drying the latex of the immature poppy capsules of a selected stably reproducing Papaver somnferum having an expressed, stable heritable trait of a higher rcticuline than phenanthrene alkaloid content, to produce opium having an (S)-rcticuline to phenanthrcne alkaloid ratio of 100% or greater by weight; and b) chemically extracting the (S)-reticuline from the opium.
27. 63. A method to improve the (S)-reticuline yield of a stably reproducing Papaver somniferum, the method comprising the steps of: a) exposing at least one poppy seed of Papaver somniferum to a mutagenizing agent; b) growing the at least one poppy seed to produce a plant bearing a leaf or an immature poppy capsule, optionally thiough multiple self fertilized generations; c) sampling the leaf or poppy capsule for the presence of (S)-reticuline, morphine and codeine; and d) repeating steps a) to c) until a poppy plant of Papaver somniferum is obtained having an (S)-reticulinc to phenanthrene alkaloid ratio of 100% or greater by weight as an expressed, stable heritable trait. 201043696 I COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30 03 9679 3111 Blake Dawson Waldron 16-17:19 30-11-2006 13124 VD 0 O o
28. 64. A method for purifying reticuline from an aqueous extract of poppy straw comprising the following steps: fl mixing said extract with toluene at near neutral pH and separating the aqueous and the non-aqueous phases; (ii) mixing the aqueous phase from step with toluene at pH of about 9.0 to M about 9,4 and separating the aqueous and the non-aqueous phases; (iii) extracting reticuline from the non-aqueous phase by caustic extraction. A method according to claim 64, wherein step is repeated before proceeding to step (ii).
29. 66. A method according to claim 64 or claim 65, wherein step (ii) is repeated before proceeding to step (iii).
30. 67. A method according to any one of claims 64 to 66, wherein pH in step is about 6.8.
31. 68. A method according to any one of claims 64 to 67, wherein plH in step (ii) is about 9.3.
32. 69. A method according to any one of claims 64 to 68, further comprising: (iv) mixing the caustic extract of step (iii) with toluene at pH of about 8.5 to about 9.5 and separating the aqueous and the non-aqueous phases; mixing the non-aqueous phase from step (iv) with water at acidic pH, and separating the aqueous and the non-aqueous phases; and (vi) adding alkali to aqueous phase at ambient temperature, ageing for a time sufficient to induce formation of a precipitate and collecting precipitate containing reticuline. A method according to claim 69, wherein steps (iv) and/or are repeated.
33. 71. A method according to claim 69 or claim 70, wherein pH in step (iv) is about 9.3. 201043696 I COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30 039679 3111 Blake Dawson Waldron 16:17:33 30-11-2006 14124 0 O S36. S72. A method according to any one of claims 69 to 71, wherein pll in step is about
34. 73. A method according to any one of claims 69 to 72, wherein alkali is added to 0 achieve a pH of about 9.3. C] 5 74. (S)-rcticulinc obtained by a method according to any one of claims 64 to 73. 2 201043696 I COMS ID No: SBMI-05523307 Received by IP Australia: Time 16:21 Date 2006-11-30